Bisacodyl and Electrocardiogram qt prolonged - a phase IV clinical study of FDA data

Summary:

Electrocardiogram qt prolonged is reported as a side effect among people who take Bisacodyl (bisacodyl), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Miralax, and have Gastroesophageal reflux disease.

The phase IV clinical study analyzes which people have Electrocardiogram qt prolonged when taking Bisacodyl. It is created by eHealthMe based on reports of 18,779 people who have side effects when taking Bisacodyl from the FDA, and is updated regularly.

What is Bisacodyl?

Bisacodyl has active ingredients of bisacodyl. It is often used in constipation. eHealthMe is studying from 18,852 Bisacodyl users. Check the latest studies of Bisacodyl.

What is Electrocardiogram qt prolonged?

Electrocardiogram qt prolonged is found to be associated with 1,394 drugs and 1,518 conditions by eHealthMe. Check the latest studies of Electrocardiogram qt prolonged.

On Jul, 20, 2026

18,779 people reported to have side effects when taking Bisacodyl.
Among them, 66 people (0.35%) have Electrocardiogram qt prolonged.

Could Bisacodyl cause Electrocardiogram qt prolonged?

Among these 66 people:

How long have people been on Bisacodyl when they have Electrocardiogram qt prolonged? *

What is the gender of people who have Electrocardiogram qt prolonged when taking Bisacodyl? *

female: 52.38 %
male: 47.62 %

What is the age of people who have Electrocardiogram qt prolonged when taking Bisacodyl? *

What are other drugs people take besides Bisacodyl? *

What are other side effects people have besides Electrocardiogram qt prolonged? *

Memory Loss: 8 people, 12.12%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 7 people, 10.61%
Convulsive Threshold Lowered: 7 people, 10.61%
Weakness: 6 people, 9.09%
Drug Level Increased: 5 people, 7.58%
Nausea And Vomiting: 5 people, 7.58%
Fainting (loss of consciousness and postural tone): 5 people, 7.58%
Drug Ineffective: 5 people, 7.58%
Schizoaffective Disorder (a mental disorder characterized by disordered thought): 5 people, 7.58%
Macular Degeneration (painless eye condition that leads to the gradual loss of central vision): 5 people, 7.58%

What are the existing conditions these people have? *

Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 14 people, 21.21%
Insomnia (sleeplessness): 10 people, 15.15%
Pain: 10 people, 15.15%
Depression: 10 people, 15.15%
Fever: 9 people, 13.64%
Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 7 people, 10.61%
Osteoporosis (bones weak and more likely to break): 7 people, 10.61%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 6 people, 9.09%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 6 people, 9.09%
Abdominal Discomfort: 5 people, 7.58%

* Approximation only. Some reports may have incomplete information.

Do you take Bisacodyl and have Electrocardiogram qt prolonged?

- Check whether Electrocardiogram qt prolonged is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Bisacodyl:

Bisacodyl (18,852 reports)

Browse all side effects of Bisacodyl:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Electrocardiogram qt prolonged:

Electrocardiogram qt prolonged (1,394 drugs)

Browse all the conditions that are associated with Electrocardiogram qt prolonged:

Electrocardiogram qt prolonged (1,518 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on bisacodyl (the active ingredients of Bisacodyl) and Bisacodyl (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.